to sell or not to sell ?, page-9

NAB from a fundemental view looks better than it did pre xmas. it looked like they were paying too much for AXA and price has reflected that underperforming the sector since but things are changing . last week AXA gave a profit upgrade for earnings release on feb17 pegging profit after tax at $675 mill with 2billion shares on issue we get EPS in the 33c range which is 5c above consensus . think this might stop the rot to a degree price wise and give them the chance to get the rights issue out at a better price reducing dilution . this general correction is the one thing negating this AXA result atm but it must be said since AXA news is out NAB has held up better relatively to peers . looking at forwards earnings multiple compared to peers NAB is trading at a good discount , looking forwards NAB looks to have the best upside potential . AXA result date worth watching for IMO